These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36124779)

  • 1. Generalized lichen sclerosus et atrophicus combined with ankylosing spondylitis responding to secukinumab.
    Ye Q; Chen KJ; Jia M; Deng LJ; Fang S
    Scand J Rheumatol; 2023 Mar; 52(2):217-218. PubMed ID: 36124779
    [No Abstract]   [Full Text] [Related]  

  • 2. Secukinumab may be a valid treatment option in patients with CNS demyelination and concurrent ankylosing spondylitis: Report of two clinical cases.
    Cortese A; Lucchetti R; Altobelli A; Conte A; Primavera M; Valesini G; Millefiorini E; Scrivo R
    Mult Scler Relat Disord; 2019 Oct; 35():193-195. PubMed ID: 31398658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological comparison of morphea and lichen sclerosus et atrophicus.
    Nishioka S
    Kurume Med J; 1997; 44(2):83-90. PubMed ID: 9255051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lichen sclerosus et atrophicus in pediatric and adult male patients with congenital and acquired phimosis.
    Jasaitiene D; Valiukeviciene S; Vaitkiene D; Jievaltas M; Barauskas V; Gudinaviciene I; Franke I; Gollnick H
    Medicina (Kaunas); 2008; 44(6):460-6. PubMed ID: 18660641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.
    Baeten D; Baraliakos X; Braun J; Sieper J; Emery P; van der Heijde D; McInnes I; van Laar JM; Landewé R; Wordsworth P; Wollenhaupt J; Kellner H; Paramarta J; Wei J; Brachat A; Bek S; Laurent D; Li Y; Wang YA; Bertolino AP; Gsteiger S; Wright AM; Hueber W
    Lancet; 2013 Nov; 382(9906):1705-13. PubMed ID: 24035250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acral lichen sclerosus et atrophicus].
    Steff M; Toulemonde A; Croue A; Lemerle E; Le Corre Y; Verret JL
    Ann Dermatol Venereol; 2008 Mar; 135(3):201-4. PubMed ID: 18374851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Anti-Interleukin-17A Monoclonal Antibody Secukinumab in Treatment of Ankylosing Spondylitis: A Meta-Analysis.
    Katsevman GA; Mariscal G; Barrios C; Domenech-Fernández P; Ziembinski C; Bhatia S
    Monoclon Antib Immunodiagn Immunother; 2020 Oct; 39(5):160-166. PubMed ID: 33001775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays.
    Lukowsky A; Muche JM; Sterry W; Audring H
    J Invest Dermatol; 2000 Aug; 115(2):254-9. PubMed ID: 10951243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus et atrophicus.
    Kaya G; Augsburger E; Stamenkovic I; Saurat JH
    J Invest Dermatol; 2000 Dec; 115(6):1054-8. PubMed ID: 11121141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extragenital lichen sclerosus et atrophicus: about a case].
    Zemmez Y; Amraoui ME; Bouhamidi A; Azhari JE; Ismaili N; Benzekri L; Meziane M; Hassam B; Senouci K
    Pan Afr Med J; 2016; 25():190. PubMed ID: 28292152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary.
    Fonti GL; Chimenti MS; Greco E; Boffa L; Conigliaro P; Triggianese P; Perricone R
    Clin Exp Rheumatol; 2021; 39(1):223. PubMed ID: 32452349
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to: Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary.
    Macaluso F; Guggino G; Ciccia F
    Clin Exp Rheumatol; 2021; 39(1):224. PubMed ID: 32452343
    [No Abstract]   [Full Text] [Related]  

  • 13. Infantile pyramidal protrusion as a manifestation of lichen sclerosus et atrophicus.
    Cruces MJ; De La Torre C; Losada A; Ocampo C; García-Doval I
    Arch Dermatol; 1998 Sep; 134(9):1118-20. PubMed ID: 9762025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleredema of Buschke associated with lichen sclerosus: Three cases.
    Venturi M; Damevska K; Ferreli C; Pinna AL; Atzori L; Gocev G; Rongioletti F
    Indian J Dermatol Venereol Leprol; 2020; 86(3):272-277. PubMed ID: 30289118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma in long-standing untreated lichen sclerosus et atrophicus of the penis.
    Kanwar AJ; Thami GP; Kaur S; Mohan H; Attri AK; Kaur C
    Urol Int; 2002; 68(4):291-4. PubMed ID: 12053035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial lichen sclerosus et atrophicus in association with CREST syndrome: a case report.
    Fitzgerald EA; Connelly CS; Purcell SM; Kantor GR
    Br J Dermatol; 1996 Jun; 134(6):1144-6. PubMed ID: 8763444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining secukinumab and fingolimod to successfully treat ankylosing spondylitis and multiple sclerosis - A novel approach.
    Nisar MK
    Biologicals; 2019 Jul; 60():93-94. PubMed ID: 31204079
    [No Abstract]   [Full Text] [Related]  

  • 18. Acral lichen sclerosus et atrophicus--case report.
    Viana Fde O; Cavaleiro LH; Unger DA; Miranda MF; Brito AC
    An Bras Dermatol; 2011; 86(4 Suppl 1):S82-4. PubMed ID: 22068779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world experience of secukinumab treatment for ankylosing spondylitis at the Royal National Hospital for Rheumatic Diseases, Bath.
    Williams T; Wadeley A; Bond D; Cavill C; Freeth M; Sengupta R
    Clin Rheumatol; 2020 May; 39(5):1501-1504. PubMed ID: 31989323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic criteria, severity classification and guidelines of lichen sclerosus et atrophicus.
    Hasegawa M; Ishikawa O; Asano Y; Sato S; Jinnin M; Takehara K; Fujimoto M; Yamamoto T; Ihn H
    J Dermatol; 2018 Aug; 45(8):891-897. PubMed ID: 29265410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.